Clinical Trials Logo

Rhinitis, Allergic, Seasonal clinical trials

View clinical trials related to Rhinitis, Allergic, Seasonal.

Filter by:

NCT ID: NCT00117832 Completed - Clinical trials for Rhinitis, Allergic, Seasonal

Nasal Ocular Reflexes Contribute to Eye Symptoms

Start date: March 2005
Phase: N/A
Study type: Interventional

Eye symptoms of tearing, redness and itching frequently occur in patients with allergic rhinitis or hayfever. The purpose of this trial is to study whether placing an allergen (a substance that causes allergies) directly in your nose can cause you to have eye symptoms as well as nasal symptoms.

NCT ID: NCT00115622 Completed - Clinical trials for Seasonal Allergic Rhinitis

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as "hay fever", it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.

NCT ID: NCT00115089 Completed - Clinical trials for Rhinitis, Allergic, Seasonal

7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis

Start date: July 2005
Phase: Phase 2
Study type: Interventional

This is a study of the effectiveness and safety of a new nasal spray for the relief of the symptoms of seasonal allergies. The agents being compared are: R926112 (a novel anti-allergy medicine), Beconase (beclomethasone dipropionate, an established FDA approved steroid treatment), and an inactive placebo. The study hypothesis is that R926112 will be superior to placebo at the end of a week of testing and evaluation. The study does not have the power to determine how R926112 compares to Beconase.

NCT ID: NCT00107757 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Seasonal Allergic Rhinitis In Pediatric Subjects

Start date: March 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.

NCT ID: NCT00092885 Completed - Clinical trials for Rhinitis, Allergic, Seasonal

An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

Start date: March 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the effect of an approved medication on the symptoms of seasonal allergic rhinitis (a seasonal variety of inflammation of the mucous membrane of the nose) in patients who are experiencing symptoms of seasonal allergic rhinitis and asthma.

NCT ID: NCT00078195 Completed - Allergy Clinical Trials

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

Start date: April 2003
Phase: Phase 2
Study type: Interventional

A series of allergy shots may reduce symptoms of seasonal ragweed allergies. This study will determine whether taking a drug called omalizumab (also known as Xolair) before getting the allergy shots is more effective than allergy shots alone or other treatments, such as prescription antihistamines.

NCT ID: NCT00070707 Completed - Asthma Clinical Trials

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Start date: April 3, 2003
Phase: Phase 4
Study type: Interventional

This study will compare mometasone nasal spray to placebo in treating the nasal and asthma symptoms experienced by participants with seasonal allergic rhinitis (SAR) and concomitant asthma.